Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Targeting Lower Arterial Oxygen Saturations to Reduce Oxygen Toxicity and Oxidative Stress in Very Preterm Infants: The Canadian Oxygen Trial (COT)

NCT00637169 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT00637169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00637169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Targeting Lower Arterial Oxygen Saturations to Reduce Oxygen Toxicity and Oxidative Stress in Very Preterm Infants: The Canadian Oxygen Trial (COT)
Lead sponsor
McMaster University
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2006
Completion date
December 31, 2012
Enrollment
1,201 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory insufficiency of prematurity